跳至主要内容
临床试验/EUCTR2015-004901-18-Outside-EU/EEA
EUCTR2015-004901-18-Outside-EU/EEA进行中(未招募)1 期

Clinical Evaluation of lamotrigine in Epilepsy

GlaxoSmithKline Research & Development0 个研究点目标入组 102 人开始时间: 2016年8月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Epilepsy with partial seizures
  • - Tonic clonic seizures
  • - Generalized seizures of Lennox-Gastaut
  • - Subjects whose seizures are easily recognizable at least one seizure per month and counts for 8 consecutive weeks prior to the start of the study drug.
  • - Concurrent AEDs: Subjects taking concurrent VPA.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 57
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 45
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Previous participation in a study of Lamictal
  • - Known hypersensitivity to any drugs
  • - Pregnant women
  • - nursing mothers
  • - women who may be pregnant
  • - women contemplating pregnancy during the study period

研究者

相似试验